Patents by Inventor Victoria Rimkunas

Victoria Rimkunas has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • A METHOD FOR TREATING CANCER WITH AN ORAL DOSAGE FORM OF AN ESTROGEN RECEPTOR-ALPHA INHIBITOR
    Publication number: 20220226300
    Abstract: The present invention relates to pharmaceutical compositions comprising an inhibitor of human ER?, and methods of cancer therapy using the ER? inhibitor. In particular, described herein are dosages of H3B-6545 with defined pharmacokinetic (PK) profiles that allow the inhibitor to be efficaciously and safely administered to a human subject in need thereof.
    Type: Application
    Filed: May 15, 2020
    Publication date: July 21, 2022
    Applicant: Eisai R&D Management Co., Ltd.
    Inventors: Jianjun XIAO, Nathalie M. RIOUX, Victoria RIMKUNAS
  • Compositions and methods for detecting EGFR in cancer
    Patent number: 10000568
    Abstract: The invention discloses binding agents to the E746-A750 deletion and the L858R point mutations in the epidermal growth factor receptor (EGFR) molecule, and methods for use thereof, including methods for the diagnosis and treatment of cancer.
    Type: Grant
    Filed: April 10, 2009
    Date of Patent: June 19, 2018
    Assignee: Cell Signaling Technology, Inc.
    Inventors: Ting-Lei Gu, Jiong Wu, Susan Kane, Jian Yu, Herbert Haack, James Wieler, Jun-Ming Cai, Victoria Rimkunas
  • PREDICTING TUMOR RESPONSES TO ANTIBODIES AGAINST HEPATOCYTE GROWTH FACTOR (HGF) AND/OR ITS COGNATE RECEPTOR, C-MET
    Publication number: 20170306415
    Abstract: The present invention provides methods for selecting a therapy for, or for providing a treatment to, a patient having a cancer. The methods of the present invention comprise detecting the protein biomarkers c-Met, HGF, and EpCAM in cancer cells or cancerous tissues of a subject, and predicting the subject's responsiveness to treatment with a c-Met-targeted or other HGF-inhibitory treatment, thereby enabling the selection and administration of an effective therapeutic.
    Type: Application
    Filed: October 1, 2015
    Publication date: October 26, 2017
    Applicant: Merrimack Phamaceuticals, Inc.
    Inventors: Adnan ABU-YOUSIF, Aaron FULGHAM, Brian HARMS, Gavin MACBEATH, Victoria RIMKUNAS
  • COMPOSITIONS AND METHODS FOR DETECTING EGFR IN CANCER
    Publication number: 20120093837
    Abstract: The invention discloses binding agents to the E746-A750 deletion and the L858R point mutations in the epidermal growth factor receptor (EGFR) molecule, and methods for use thereof, including methods for the diagnosis and treatment of cancer.
    Type: Application
    Filed: April 10, 2009
    Publication date: April 19, 2012
    Inventors: Ting-Lei Gu, Jiong Wu, Susan Kane, Jian Yu, Herbert Haack, James Wieler, Jun-Ming Cai, Victoria Rimkunas